Now available in select US geographies.

Avation Medical unveils first non-invasive, closed-loop wearable neuromodulation for bladder treatment to urology community at 2024 SUFU Conference

Vivally is the first FDA-cleared, noninvasive, closed-loop, wearable tibial neuromodulation system and digital companion app for urge urinary incontinence and urinary urgency caused by overactive

Avation Medical raises $22M+ from impressive line-up of new global investors to jump-start sales of the first closed-loop wearable neuromodulation technology for bladder treatment

Vivally is the first FDA-cleared, noninvasive, closed-loop, wearable tibial neuromodulation system and digital companion app for urge urinary incontinence and urinary urgency caused by overactive

Multi-center study published in Urology confirms efficacy and safety of Avation Medical’s noninvasive Vivally® System for OAB

Vivally is the first FDA-cleared, noninvasive, closed-loop, wearable tibial neuromodulation system and digital companion app for urge urinary incontinence and urinary urgency caused by overactive

Avation Medical’s Bladder Control Therapy Receives Award for Most Innovative Wearable

Vivally® System, wearable closed-loop neuromodulation system and mobile application for urge incontinence and urinary urge, recognized by MedTech Breakthrough Awards program for 2023

Avation Medical Announces US FDA 510(k) Clearance for The Vivally® System, a wearable bladder control therapy and mobile app to treat patients with urinary urgency and urge urinary incontinence.

Revolutionary smart, wearable bladder control therapy and mobile app provides a new option for urge urinary incontinence and urinary urgency for patients with no surgery, implants,

The Intersection of Neuromodulation and Personalized Medicine

Avation Medical is pioneering a wearable digital therapy that could soon change the way that chronic health conditions are monitored and treated.

Kimberly Wilkinson of Avation Medical awarded Top 25 Healthcare Tech Leaders of Houston 2022

Avation Medical’s Kimberly Wilkinson was recognized by The Healthcare Technology Report in its recent announcement of The Top 25 Healthcare Tech Leaders of Houston, TX

Avation CEO, Jill Schiaparelli, to join all-female panel with executives from Medtronic, Danaher, and other distinguished life science companies to discuss digital health innovations at BioMedDevice Boston

Medical Devices and Diagnostic Industries announced a keynote panel discussion at BIOMedevice Boston to occur on Thu, Sep 29, 2022. Six female medical device industry

Avation Medical CEO, Jill Schiaparelli, awarded one of the Top 25 Women Leaders in Consumer Health Tech for 2022 by The Healthcare Technology Report

Avation Medical is proud to share that our CEO, Jill Schiaparelli, has been named one of the Top 25 Women Leaders in Consumer Health Tech

Avation Medical to present clinical evidence on pioneering wearable neuromodulation and digital behavioral support system at the American Urogynecologic Society (AUGS) 2022 Scientific Meeting

Dr. Colin Goudelocke, investigator in the “FreeOAB Study”, will present the results of Avation Medical’s recent clinical trial evaluating the safety and efficacy of a
Skip to content